Certified by Founder
Lodge
Upfront Diagnostics
start up
United Kingdom
- Cambridge, England
- 27/06/2023
- Seed
- $2,037,200
Upfront diagnostics was founded in November 2017 in Cambridge, United Kingdom. We are a group of Cambridge students and young entrepreneurs focused on discovering biomarkers that can be applied to improve medical diagnosis.
We have built the first blood test for large vessel occlusion stroke diagnosis called "LVOne", enabling a faster and more accurate stroke diagnosis that improves treatment and can help clinicians saving lives.
We believe in excellence, bringing products that help clinicians, paramedics and nurses to deliver a better care to patients in more cost-effective ways.
#TimeisLife
- Industry Biotechnology
- Website https://upfrontdiagnostics.com/
- LinkedIn https://www.linkedin.com/company/upfrontdiagnostics/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)